Monte Rosa Therapeutics Inc (GLUE)

Monte Rosa Therapeutics Inc (GLUE) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $839M; returns 1 day -2.4%, 1 week +11.3%, 1 year +4.4%.

Monte Rosa Therapeutics Inc. (NASDAQ: GLUE) is a clinical-stage biotechnology company that specializes in developing novel molecular glue degrader (MGD)-based medicines.

Groups GLUE belongs to

• Biotechnology
• Clinical Stage Biotech
• Life Sciences
• Biopharmaceutical
• Clinical Stage
• Precision Medicine
• Artificial Intelligence
• Drug Discovery
• Oncology
• Autoimmune Diseases
• AI in Healthcare

GLUE financial model: income statement, cash flow and balance sheet